CClinicalTrials.gg
CompletedNCT03308019Updated Oct 12, 2017

Adjunct Photodynamic Therapy in Chronic Periodontitis Among Cigarette-smokers.

An interventional study of Photodynamic therapy and Scaling and root planing (SRP) in Chronic Periodontitis and Smoking, sponsored by King Saud University. Completed. Open to male participants aged 42 Years to 52 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-10-12.

Sponsored by King Saud University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
83
Allocation
Randomized
Ages
42 Years to 52 Years
Sex
Male
01

Study summary

This study evaluates the efficacy of scaling and root planing with and without adjunct antimicrobial photodynamic therapy (aPDT) in the treatment of chronic periodontitis (CP) among cigarette-smokers and never-smokers.

Read the detailed description

The following inclusion criteria were entailed: (a) Self-reported habitual cigarette-smokers; (b) self-reported never-smokers; (c) patients with CP (presence of at least 30% sites with ≥ 3 mm of CAL and PD ≥ 3 mm 18, 19 ). The exclusion criteria were as follows: (a) patients with systemic diseases such as acquired immune deficiency syndrome/HIV and diabetes mellitus; (b) habitual smokeless tobacco product and alcohol users; (c) third molars and fractured teeth with embedded root remnants and edentulous individuals; (d) patients with misaligned teeth; and (e) patients that reported to have used antibiotics, non-steroidal anti-inflammatory drugs and/or steroids within the past 90 days.

Demographic information was collected using a questionnaire. Cigarette-smokers (group-1) and never-smokers (group-2) with chronic periodontitis were included. Treatment wise, these individuals were divided into two subgroups as follows: (a) SRP alone and (b) SRP with adjunct aPDT. Periodontal parameters (plaque index [PI], bleeding on probing [BOP], clinical attachment loss [CAL] and probing pocket depth ≥4mm [PD] were measured at baseline and at 1 month and 3 months' follow-up.

02

Conditions studied

  • Chronic Periodontitis
  • Smoking
03

Who can participate

Ages eligible
42 Years to 52 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Inclusion criteria

  • Self-reported habitual cigarette-smokers.
  • Self-reported never-smokers.
  • Patients with chronic periodontitis (presence of at least 30% sites with ≥ 3 mm of CAL and PD ≥ 3 mm.

Exclusion criteria

Exclusion Criteria:

  • Patients with systemic diseases such as acquired immune deficiency syndrome/HIV and diabetes mellitus.
  • Habitual smokeless tobacco product and alcohol users.
  • Third molars and fractured teeth with embedded root remnants and edentulous individuals.
  • Patients with misaligned teeth.
  • Patients that reported to have used antibiotics, non-steroidal anti-inflammatory drugs and/or steroids within the past 90 days.
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
83 participants (actual)

Study arms

  • Experimental
    Adjunctive photodynamic therapy

    This arm will be given scaling and root planing (SRP) with adjunctive photodynamic therapy (aPDT)

    Device: Photodynamic therapy · Procedure: Scaling and root planing (SRP)

  • Active comparator
    Dental scaling

    This arm will be given scaling and root planing (SRP) only

    Device: Photodynamic therapy · Procedure: Scaling and root planing (SRP)

Interventions

  • DevicePhotodynamic therapy

    In groups 1 and 2, aPDT was performed after SRP. The protocol for aPDT is described elsewhere. Briefly, using a blunt needle, 0.005% of Methylene blue was applied into the periodontal pocket and left in place for 10 seconds. The dye was then irradiated with a diode laser (670 nanometers) at 150 milliwatts. In each dye filled periodontal pocket, laser irradiation was performed for one minute using a flexible tip. In the present study, aPDT was performed once, at baseline, by a trained dentist.

  • ProcedureScaling and root planing (SRP)

    In both groups, SRP was performed in one session under local anesthesia using handheld Gracey curettes No. 5/6. One trained dental hygienist blinded to the study groups and subgroups made 9 to 10 strokes in a vertical (apico-coronal) direction and the inclination between scaler tips and roots was maintained as zero. When the curved explorer indicated a smooth and hard dental surface, SRP was judged as completed. In all individuals, SRP was done in one session without any assigned time limit for completion.

05

What researchers measure

Primary outcomes

  1. Probing depth

    Probing depth will be measured as the distance from the gingival margin to the location of the tip of the probe to the nearest millimeter. Pocket depth assessment was carried out at 6 sites per tooth for all teeth (disto-buccal, mid-buccal, mesio-buccal, mesio-lingual, mid-lingual and disto-lingual)

    Time frame: 3 months

  2. Clinical attachment level gain

    Clinical attachment level gain will be calculated for each site as the sum of probing depth and gingival recession. The CAL was recorded at 6 sites per tooth for all teeth (disto-buccal, mid-buccal, mesio-buccal, mesio-lingual, mid-lingual and disto-lingual) except third molars.

    Time frame: 3 months

Secondary outcomes

  1. Plaque index

    Plaque index will be detected visually by running the probe at 4 sites per tooth (mesio-buccal, disto-buccal, mid-buccal and palatal/lingual) for absence or presence of plaque, based on dichotomous scoring system. The scores ranged as follows; 0 - No visible plaque 1 - Visible plaque

    Time frame: 3 months

  2. Bleeding on probing

    Bleeding on probing will be recorded at 4 sites per tooth (mesio-buccal, disto-buccal, mid-buccal, and palatal/lingual) for absence or presence of bleeding, based on dichotomous scoring system. The scores ranged as follows; 0 - No visible bleeding 1 - Visible bleeding

    Time frame: 3 months

06

Study locations

No study locations are listed for this record.

07

References and documents

Individual participant data

Plan to share: Yes — De-identified individual participant data for all primary outcome measures will be made available

Supporting information: Study protocol, Sap, Icf, Csr, Analytic code

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT03308019
Lead sponsor
King Saud University
Responsible party
Zohaib Akram (Director, Clinical Research, King Saud University) — Principal investigator
First posted
Oct 12, 2017
Start date
Feb 16, 2016
Primary completion
Jul 2, 2017
Completion
Sep 16, 2017
Last update
Oct 12, 2017

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion